Allergic rhinitis affects an estimated 15% of the US population and is associated with impaired quality of life. JAMA Deputy Editor Mary McGrae McDermott, MD, discusses current evidence regarding the diagnosis and treatment of allergic rhinitis with author Jonathan A. Bernstein, MD, College of Medicine, University of Cincinnati.
Related Content:
Influenza Vaccination in 2019-2020
How Adolescent Boys’ Need for Friendship Affects Their Mental Health
Emerging Applications for Ketamine
Understanding Lipids and Cardiovascular Risk Through Mendelian Randomization
Pancreatic Cancer
Personal Protective Equipment for Health Care Infection Control
Improving Uptake of Preexposure Prophylaxis (PrEP) for HIV in Primary Care
Update in Clinical Infectious Diseases 2019-2020
A New Path for Gun Research Funding
Bariatric Surgery and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity
Management of Heart Failure in 2019-2020, Part 2
Management of Heart Failure in 2019-2020, Part 1
The Influence of Obesity on Cancer
Responsible Use of Opioids to Treat Cancer Pain
Diagnosing Menopause
Guns and Suicide
Subclinical Hypothyroidism
The Clinical Ramifications of Dense Breasts
California’s Attempt to Improve Measles Vaccination Rates
Reducing the Intensity of Antiplatelet Therapy Following Coronary Stent Procedures
Create your
podcast in
minutes
It is Free
Good Mood Revolution
JAMA Editors’ Summary
JAMA Medical News
JAMAevidence The Rational Clinical Examination
JAMA Psychiatry Author Interviews
JAMA Internal Medicine Author Interviews